Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth

Journal of General Virology

Volumn 78, Issue 12, 1997, Pages 3303-3310

  Monteil, M ^a   Le Potier, M F ^b   Cariolet, R ^b   Houdayer, C ^b   Eloit, M ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; PSEUDORABIES VACCINE; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFECTIVE VIRUS; GENE TRANSFER; MOLECULAR CLONING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; SWINE; VIRUS IMMUNITY;

ADENOVIRIDAE; ANIMALIA; HERPETOVIRUS; SUID HERPESVIRUS 1; SUS SCROFA;

EID: 0030825934     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-12-3303     Document Type: Article

References (30)

1. Adam, M., Le Potier, M. F. & Eloit, M. (1994). Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies. Veterinary Microbiology 42, 205-215.
2. Ali, M., Lemoine, N. R. & Ring, C. J. A. (1994). The use of DNA viruses as vectors for gene therapy. Gene Therapy 1, 367-384.
3. Ambriovic, A., Adam, M., Monteil, M., Paulin, D. & Eloit, M. (1997). Efficacy of replication defective vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells. Virology (in press).
4. Andries, K., Pensaert, M. B. & Vandeputte, J. (1978). Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows. American Journal of Veterinary Research 39, 1282-1285.
5. Coe, N. E. & Mengeling, W. L. (1990). Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus. Archives of Virology 110, 137-142.
6. Danko, I. & Wolff, J. A. (1994). Direct gene transfer into muscle. Vaccine 12, 1499-1502.
7. Davis, H. L. & Whalen, R. G. (1995). DNA-based immunization. In Molecular and Cell Biology of Human Gene Therapeutics, pp. 368-387. Edited by G. Dickson. London: Chapman & Hall.
8. Eloit, M., Fargeaud, D., L'Haridon, R. & Toma, B. (1988). Identification of pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Archives of Virology 99, 45-56.
9. Eloit, M., Fargeaud, D., Vannier, P. & Toma, B. (1989). Development of an ELISA test to differentiate between animals either vaccinated with or infected by Aujeszky's disease virus. Veterinary Record 28, 91-94.
10. Eloit, M., Gilardi-Hebenstreit, P., Toma, B. & Perricaudet, M. (1990). Construction of a defective adenovirus vector expressing the pseudorabies virus gp50 and its use as a live vaccine. Journal of General Virology 71, 2179-2183.
11. Ganne, V., Eloit, M., Lavai, A., Adam, M. & Trouve, G. (1994). Enhancement of the efficacy of a replication defective adenovirus vectored vaccine by the addition of oil adjuvants. Vaccine 12, 1190-1196.
12. Ghiasi, H., Cai, S., Slanima, S., Nesburn, A. B. & Wechsler, S. L. (1996). Vaccination of mice with herpes simplex type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Research 28, 147-157.
13. Gilgenkrantz, H., Duboc, D., Juillard, V., Couton, D., Pavirani, A., Guillet, J. G., Briand, P. & Kahn, A. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors - role of the immune response. Human Gene Therapy 6, 1265-1274.
14. Graham, F. L., Smiley, J., Russel, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36, 59-72.
15. Haddada, E., Lopez, M., Martinache, C., Ragot, T., Abina, M. A. & Perricaudet, M. (1993). Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochemical and Biophysical Research Communications 3, 1174-1183.
16. Ishii, H., Kobayashi, Y., Kuroki, M. & Kodama, Y. (1988). Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. Journal of General Virology 69, 1411-1414.
17. Juillard, V., Villefroy, P., Godfrin, D., Pavirani, A., Venet, A. & Guillet, J. G. (1995). Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. European Journal of Immunology 25, 3467-3473.
18. Kasseisler, A., Falckpedersen, E., Elfenbein, D. H., Alvira, M., Buttrick, P. M. & Leinwand, L. A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1, 395-402.
19. Lowrie, D. B., Tascon, R. E., Colston, M. J. & Silva, C. L. (1994). Towards a DNA vaccine against tuberculosis. Vaccine 12, 1537-1540.
20. Marchioli, C., Yancey, R., Petrovskis, E., Timmins, J. & Post, L. (1987). Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. Journal of Virology 61, 3977-3982.
21. Monteil, M., Le Potier, M. F., Guillotin, J., Cariolet, R., Houdayer, C. & Eloit, M. (1996). Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Veterinary Research 27, 443-452.
22. Riviere, M., Tartaglia, J., Perkus, M., Norton, E., Bongermino, C., Lacoste, F., Duret, C., Desmettre, P. & Paoletti, E. (1992). Protection of mice and swine from pseudorabies virus by vaccinia virus-based recombinants. Journal of Virology 66, 3424-3434.
23. Stellmann, C., Vannier, P., Chappuis, G., Brun, A., Dauvergne, M., Fargeaud, D., Bugand, M. & Colson, X. (1989). The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. Journal of Biological Standards 17, 17-27.
24. Ulmer, J. B., Donelly, J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., Dewitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L. & Liu, M. A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
25. Ulmer, J. B., Deck, R. R., Dewitt, C. M., Friedman, A., Donnelly, J. J. & Liu, M. A. (1994). Protection immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12, 1541-1544.
26. Vannier, P., Hutet, E., Bourgueil, E. & Cariolet, R. (1991). Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Veterinary Microbiology 29, 213-223.
27. Vannier, P., Hutet, E. & Cariolet, R. (1995). Influence of passive immunity on pig immunization with deleted Aujeszky's disease vaccines measured by the amount of wild virus excretion after challenge. Veterinary Microbiology 43, 53-63.
28. Wathen, M. W. & Wathen, L. M. K. (1984). Isolation, characterisation and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. Journal of Virology 51, 57-62.
29. Yang, Y. P., Nunes, F. A., Berencsi, K., Gonczol, E., Engelhardt, J. F. & Wilson, J. M. (1994). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genetics 7, 362-369.
30. Yang, Y., Li, Q., Ertl, H. C. & Wilson, J. M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. Journal of Virology 69, 2004-2015.